NCIt definition : An immunoglobulin G1 (IgG1) monoclonal antibody directed against the spike (S) protein
of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially
be used for immunization against the Coronavirus disease 2019 (COVID-19). Upon administration,
rimteravimab specifically targets and binds to the receptor-binding domain (RBD) of
the S protein, thereby blocking viral attachment and entry into human cells and may
thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate
recovery, and may potentially provide temporary protection against infection with
SARS-CoV-2.;
Semantic type(s)